(Q40932315)

25 September 2017

1 reference

title

Guidelines for general practitioners administering thrombolytics (English)

1 reference

25 September 2017

1 reference

J Rawles

1

1 reference

25 September 2017

publication date

1 October 1995

1 reference

25 September 2017

1 reference

25 September 2017

volume

50

1 reference

25 September 2017

issue

4

1 reference

25 September 2017

page(s)

615-625

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199550040-00004

25 September 2017

exact match

0 references

cites work

Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial

1 reference

12 December 2020

Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction

1 reference

12 December 2020

Decreased incidence of ventricular late potentials after successful thrombolytic therapy for acute myocardial infarction

1 reference

12 December 2020

Mobile coronary care and community mortality from myocardial infarction

1 reference

12 December 2020

The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction

1 reference

12 December 2020

GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico

1 reference

12 December 2020

Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. AIMS Trial Study Group

1 reference

12 December 2020

Effect of streptokinase on left ventricular modeling and function after myocardial infarction: the GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico) Trial

1 reference

12 December 2020

One thousand heart attacks in Grampian: the place of cardiopulmonary resuscitation in general practice

1 reference

12 December 2020

Impact of resuscitation and thrombolysis on mortality rate from acute myocardial infarction

1 reference

12 December 2020

Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).

1 reference

12 December 2020

Intravenous recombinant tissue plasminogen activator (rt-PA) and urokinase in acute myocardial infarction: results of the German Activator Urokinase Study (GAUS)

1 reference

12 December 2020

Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction

1 reference

12 December 2020

Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI)

1 reference

12 December 2020

Magnitude of benefit from earlier thrombolytic treatment in acute myocardial infarction: new evidence from Grampian region early anistreplase trial (GREAT)

1 reference

12 December 2020

Potential impact of emergency intervention on sudden deaths from coronary heart disease in Glasgow

1 reference

12 December 2020

Time delays in provision of thrombolytic treatment in six district hospitals. Joint Audit Committee of the British Cardiac Society and a Cardiology Committee of Royal College of Physicians of London

1 reference

12 December 2020

Treatment of myocardial infarction and angina. Review underestimated the benefit of early thrombolysis

1 reference

12 December 2020

Association of patient delay with symptoms, cardiac enzymes, and outcome in acute myocardial infarction

1 reference

12 December 2020

Assessment of the practicality and safety of thrombolysis with anistreplase given by general practitioners

1 reference

12 December 2020

Emergency care in general practice. British Heart Foundation recommends early defibrillation

1 reference

12 December 2020

Intravenous urokinase in acute myocardial infarction

1 reference

12 December 2020

Randomised trial of late thrombolysis in patients with suspected acute myocardial infarction. EMERAS (Estudio Multicéntrico Estreptoquinasa Repúblicas de América del Sur) Collaborative Group

1 reference

12 December 2020

Intracoronary thrombolysis in patients with acute myocardial infarction: comparison of the efficacy of urokinase with streptokinase

1 reference

12 December 2020

Reduction in incidence of inducible ventricular tachycardia after myocardial infarction by treatment with streptokinase during infarct evolution

1 reference

12 December 2020

Thrombolysis and myocardial salvage. Results of clinical trials and the animal paradigm--paradoxic or predictable?

1 reference

12 December 2020

The effect of a mobile coronary care unit on mortality in patients with acute myocardial infarction or cardiac arrest outside hospital

1 reference

12 December 2020

Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents.

1 reference

12 December 2020

Halving of mortality at 1 year by domiciliary thrombolysis in the Grampian Region Early Anistreplase Trial (GREAT)

1 reference

12 December 2020

Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction

1 reference

12 December 2020

Feasibility, safety, and efficacy of domiciliary thrombolysis by general practitioners: Grampian region early anistreplase trial. GREAT Group

1 reference

12 December 2020

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collabo

1 reference

12 December 2020

Natural history of acute coronary heart attacks. A community study

1 reference

12 December 2020

Guidelines for the early management of patients with myocardial infarction. British Heart Foundation Working Group

1 reference

12 December 2020

ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. ISIS-3 (Third International Study of Infarct S

1 reference

12 December 2020

RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2

1 reference

12 December 2020

Patient and general practitioner delays in acute myocardial infarction

1 reference

12 December 2020

Individual risk assessment for intracranial haemorrhage during thrombolytic therapy

1 reference

12 December 2020

Intracranial hemorrhage in association with thrombolytic therapy: Incidence and clinical predictive factors

1 reference

12 December 2020

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

1 reference

12 December 2020

Earliest electrocardiographic evidence of myocardial infarction: implications for thrombolytic treatment. The GREAT Group

1 reference

12 December 2020

Effects of late administration of tissue-type plasminogen activator on left ventricular remodeling and function after myocardial infarction.

1 reference

12 December 2020

10.2165/00003495-199550040-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

25 September 2017

1033784559

0 references

1 reference